Table 1.
Open in new tab

Summary of Candida treatment pathways

Action
▪ Restrict antifungal prophylaxis
▪ Start prompt ‘early’ antifungal treatment based on risk factors
▪ Select an antifungal agent that the isolate is susceptible to
▪ Achieve adequate source control
▪ Use an adequate dose: low dose is associated with resistance
▪ Stop ‘early’ inappropriate therapy
▪ De-escalate whenever possible
▪ Check duration of therapy
Action
▪ Restrict antifungal prophylaxis
▪ Start prompt ‘early’ antifungal treatment based on risk factors
▪ Select an antifungal agent that the isolate is susceptible to
▪ Achieve adequate source control
▪ Use an adequate dose: low dose is associated with resistance
▪ Stop ‘early’ inappropriate therapy
▪ De-escalate whenever possible
▪ Check duration of therapy
Table 1.
Open in new tab

Summary of Candida treatment pathways

Action
▪ Restrict antifungal prophylaxis
▪ Start prompt ‘early’ antifungal treatment based on risk factors
▪ Select an antifungal agent that the isolate is susceptible to
▪ Achieve adequate source control
▪ Use an adequate dose: low dose is associated with resistance
▪ Stop ‘early’ inappropriate therapy
▪ De-escalate whenever possible
▪ Check duration of therapy
Action
▪ Restrict antifungal prophylaxis
▪ Start prompt ‘early’ antifungal treatment based on risk factors
▪ Select an antifungal agent that the isolate is susceptible to
▪ Achieve adequate source control
▪ Use an adequate dose: low dose is associated with resistance
▪ Stop ‘early’ inappropriate therapy
▪ De-escalate whenever possible
▪ Check duration of therapy
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close